https://en.bioecon.ru/technologies/crispr-cas/Recent content in CRISPR-Cas on BioeconHugoen-USSat, 11 Jul 2026 14:19:14 +0700https://en.bioecon.ru/technology/precision-plant-breeding-crispr/Mon, 22 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/precision-plant-breeding-crispr/Precision plant breeding combines CRISPR crop editing, AI-driven genomic selection and speed breeding to deliver trait-stacked varieties in 3–4 years — compressing a decade of conventional development into a single pipeline.https://en.bioecon.ru/technology/base-editing/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/base-editing/Base editors (CBE/ABE) make single-nucleotide changes C·G→T·A and A·T→G·C without double-strand breaks — treating monogenic disease (sickle cell, beta-thalassemia) at up to 90% efficiency with no indels.https://en.bioecon.ru/technology/crispr-screening-as-a-service/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/crispr-screening-as-a-service/Contract functional-genetic CRISPR screening (pooled sgRNA libraries, lentiviral delivery, NGS) — identifies cancer-resistance genes and drug targets in weeks.https://en.bioecon.ru/technology/personalized-regenerative-medicine/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-regenerative-medicine/Gene and cell therapy platforms for rare monogenic and oncological diseases: AAV vectors, lentiviral HSC editing, ex vivo CRISPR (Casgevy) and in vivo CRISPR (LNP delivery) now deliver durable one-time treatments approved by FDA and EMA.https://en.bioecon.ru/technology/crispr-diagnostics/Sun, 14 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/crispr-diagnostics/Cas-enzyme nucleic-acid detection — point-of-care molecular diagnostics from sample to lateral-flow readout.